Author Search Results

1

Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads

by Caroline Mangare, Sabine Tischer-Zimmermann, Sebastian B. Riese, Anna C. Dragon, Immo Prinz, Rainer Blasczyk, Britta Maecker-Kolhoff, Britta Eiz-Vesper
Published 2019-03-01

Get full text

Article

2

Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy

by Damaris A. Schillingmann, Sebastian B. Riese, Vijith Vijayan, Sabine Tischer-Zimmermann, Helga Schmetzer, Britta Maecker-Kolhoff, Rainer Blasczyk, Stephan Immenschuh, Britta Eiz-Vesper
Published 2019-01-01

Get full text

Article

3

$Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes$

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes

by Thomas Mika, Katharina Strate, Swetlana Ladigan, Clemens Aigner, Uwe Schlegel, Iris Tischoff, Sabine Tischer-Zimmermann, Britta Eiz-Vesper, Britta Maecker-Kolhoff, Roland Schroers
Published 2019-12-01

Get full text

Article

4

High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?

by Nele Carolin Heinemann, Sabine Tischer-Zimmermann, Torge Christian Wittke, Julian Eigendorf, Arno Kerling, Theodor Framke, Anette Melk, Hans-Gert Heuft, Rainer Blasczyk, Britta Maecker-Kolhoff, Britta Eiz-Vesper
Published 2020-04-01

Get full text

Article

5

CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation

by Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, Deborah Sandfort, Julia Lahrberg, Stephan Klöß, Christina Kloth, Caroline Mangare, Agnes Bonifacius, Sabine Tischer-Zimmermann, Rainer Blasczyk, Britta Maecker-Kolhoff, Barbara Uchanska-Ziegler, Hinrich Abken, Axel Schambach, Britta Eiz-Vesper
Published 2020-07-01

Get full text

Article

6

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy

by Barnstorf-Brandes, J., Baurmann, H., Blasczyk, R., Bonifacius, A., Brauns, O., Clark, C., Cornely, O.A, Eiz-Vesper, B., Gödecke, N., Goudeva, L., Hallek, M., Koch, S., Köhler, P., Lang, P., Maecker-Kolhoff, B., Martens, J., Mausberg, P., Santamorena, M.M, Schenk, J., Seiferling, D., Simon, M., Tischer-Zimmermann, S., Verboom, M., Wittig, J.
Published 2022

View Fulltext in Publisher

Article

Related Subjects